T J Qin

机构：Tongji Hospital, Huazhong University of Science and Technology · ORCID：0009-0008-9082-5394

发表论文 60 篇 · 总被引 157 次 · h-index 5

代表论文

• OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 Study (2023 · Journal of Thoracic Oncology · 被引 23)
• [Efficacy and safety analysis of venetoclax combined with hypomethylating agents for the treatment of higher-risk myelodysplastic syndromes in the real world]. (2024 · PubMed · 被引 1)
• Obesity, White Matter Hyperintensities, and Cognitive Decline: Sex-Specific DTI-ALPS Index Mediation (2026 · Stroke)
• Supplementary Figure 1 from Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2025)
• Supplementary Tables 1-3 from Efficacy and Safety of Stereotactic Body Radiotherapy Combined with Camrelizumab and Apatinib in Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2025)
• [Myelodysplastic neoplasms with acute myeloid leukemia-like mutations: clinical features, molecular profiles, and prognosis]. (2025 · PubMed)